Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Medical Genetics · SAMD9L-Associated Autoinflammatory Disease

Understanding SAMD9L-Associated Autoinflammatory Disease (SAAD)

At a Glance

SAMD9L-associated autoinflammatory disease (SAAD) is a rare genetic condition that can cause inflammation without infection and low blood counts. Some children also develop balance or eye-movement problems, and monitoring is tailored to each child because symptoms vary.

Receiving a diagnosis of SAMD9L-associated autoinflammatory disease (SAAD) can feel overwhelming, especially when most doctors you meet have never heard of it. You are likely navigating a “diagnostic odyssey”—a long journey of testing and uncertainty—to find answers for your child [1]. Because this condition was only recently identified, you may find that your family is learning alongside your medical team [2].

A Spectrum of Possibilities

SAMD9L-associated diseases are not one single condition with a predictable path. Instead, they exist on a spectrum—a range of different ways the genetic change can show up in the body. While your child may have been diagnosed with SAAD, it is helpful to understand the three main ways this genetic change typically presents:

  • SAMD9L-Associated Autoinflammatory Disease (SAAD): This pattern is characterized by severe inflammation that doesn’t come from an infection (sterile inflammation). Common signs include panniculitis (painful bumps or inflammation of the fat under the skin) and cytopenias (low blood cell counts) [2][1].
  • Ataxia-Pancytopenia (ATXPC): This pattern primarily affects the brain and the blood. Children may experience ataxia (trouble with balance and coordination) and nystagmus (involuntary eye movements) alongside low blood counts [3][4].
  • Familial Myelodysplastic Syndrome (MDS): In some families, the primary issue is a predisposition to MDS (a group of disorders where the bone marrow doesn’t make enough healthy blood cells). This can sometimes involve a specific genetic change in the blood cells called monosomy 7 [5][6].

It is important to remember that these are clinically distinct phenotypic patterns, though overlap can exist. A child might have symptoms from more than one category, or their symptoms may change over time [1][7].

Understanding the SAMD9L Gene and Inheritance

The SAMD9L gene acts like a natural brake for cell growth [1]. In children with SAAD, a genetic change causes this brake to be “stuck” in the on position. This is called a gain-of-function mutation [1]. Because the brake is always on, certain cells—especially those in the bone marrow and the immune system—cannot grow and divide as they should [8].

SAMD9L pathogenic variants are generally inherited in an autosomal dominant manner, meaning only one copy of the mutated gene from one parent is needed to cause the disorder (though de novo, or new mutations, also occur). Crucially, this gene exhibits variable penetrance, which means that even people with the exact same genetic change (like parents or siblings) may have very different symptoms or no symptoms at all [5][1]. Because of this, it is highly recommended to consult with a genetic counselor. Parental and relative testing can heavily affect medical surveillance, donor selection for a transplant, and family planning.

Why This Diagnosis Is So Rare

If you feel like you are in uncharted territory, it is because you are. The exact incidence is unknown, but it is exceptionally rare. To date, only a limited number of cases of the entire SAMD9L spectrum have been documented in medical literature worldwide [1][9].

For the specific SAAD phenotype, the numbers are even smaller—some studies have focused on groups of as few as six or seven patients at a time [2][10]. Because it is so rare, there is not yet a “standard” treatment plan that applies to everyone. Instead, doctors must tailor care to your child’s specific symptoms and blood work [1].

Navigating the Emotional Toll

The road to a SAAD diagnosis is often exhausting. Families frequently spend years visiting different specialists—hematologists for blood issues, neurologists for balance, and rheumatologists for inflammation—before the genetic cause is found [1][8].

It is normal to feel:

  • Isolated: Knowing that your child has a condition that even specialists may need to research.
  • Anxious: Dealing with the uncertainty of a “variable” disease where symptoms can shift.
  • Overwhelmed: Managing the frequent blood tests, imaging, and specialist appointments required for monitoring [6][4].

Validating these feelings is a crucial part of your child’s care. You are not just managing a genetic condition; you are navigating a complex medical system on behalf of your family. Finding a care team that is willing to collaborate with national experts and listen to your observations as a parent is essential for long-term management [1].

Common questions in this guide

What is SAMD9L-associated autoinflammatory disease?
SAAD is a rare genetic condition caused by a harmful change in the SAMD9L gene. It can lead to inflammation that is not caused by an infection, low blood cell counts, and problems involving the skin, bone marrow, or nervous system.
What symptoms can a child with a SAMD9L condition develop?
Symptoms vary widely. They can include painful inflammation under the skin, low blood cell counts, fevers or skin rashes, and, within the broader SAMD9L spectrum, poor balance, coordination problems, or involuntary eye movements.
What are the main SAMD9L disease patterns?
The three main patterns are SAAD, ataxia-pancytopenia, and familial myelodysplastic syndrome. SAAD is marked by inflammation and low blood counts, ataxia-pancytopenia affects balance and blood counts, and familial myelodysplastic syndrome involves a tendency toward bone-marrow blood-cell disorders. These patterns can overlap or change over time.
How is SAMD9L-associated disease inherited?
Most SAMD9L disease-causing variants follow an autosomal dominant pattern, meaning one altered copy of the gene can be enough to cause the condition. A new variant can also occur without a family history, and people with the same variant may have different symptoms or none. A genetic counselor can discuss testing for parents and relatives.
Why might genetic testing be confirmed with saliva or a skin sample?
A care team may confirm a SAMD9L result with a sample that is not blood, such as saliva or skin, to make sure the result accurately reflects the child’s genetic makeup. Ask the genetics team why a second sample is recommended and how the result may affect monitoring or family testing.
How is a child with SAAD monitored?
There is no single monitoring schedule for every child because symptoms and blood findings can vary. The specialist team may use regular blood counts and neurological evaluations, with the frequency based on the child’s symptoms, test results, and disease pattern.
Is there one standard treatment plan for SAAD?
Because the SAMD9L disease spectrum is rare and variable, there is not one standard plan that fits every child. Doctors tailor care to the child’s symptoms and blood counts and may coordinate among hematology, neurology, rheumatology, genetics, and experienced specialist centers.

Get notified when new evidence is published on SAMD9L-associated autoinflammatory syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: from variant interpretation to patient management.

    Sahoo SS, Erlacher M, Wlodarski MW

    Blood 2025; (145(5)):475-485 doi:10.1182/blood.2022017717.

    PMID: 39475954
  2. 2

    Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.

    de Jesus AA, Hou Y, Brooks S, et al.

    The Journal of clinical investigation 2020; (130(4)):1669-1682.

    PMID: 31874111
  3. 3

    Ataxia-pancytopenia syndrome with SAMD9L mutations.

    Gorcenco S, Komulainen-Ebrahim J, Nordborg K, et al.

    Neurology. Genetics 2017; (3(5)):e183 doi:10.1212/NXG.0000000000000183.

    PMID: 28852709
  4. 4

    Assessing Long-Term Neurologic Outcomes in SAMD9L-Related Ataxia-Pancytopenia Syndrome.

    Zingariello CD, Chen DH, Raskind WH, et al.

    Movement disorders clinical practice 2024; (11(6)):728-733 doi:10.1002/mdc3.14038.

    PMID: 38594844
  5. 5

    Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7.

    Pastor VB, Sahoo SS, Boklan J, et al.

    Haematologica 2018; (103(3)):427-437 doi:10.3324/haematol.2017.180778.

    PMID: 29217778
  6. 6

    Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.

    Erlacher M, Andresen F, Sukova M, et al.

    Haematologica 2024; (109(2)):422-430 doi:10.3324/haematol.2023.283591.

    PMID: 37584291
  7. 7

    Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.

    Tesi B, Davidsson J, Voss M, et al.

    Blood 2017; (129(16)):2266-2279 doi:10.1182/blood-2016-10-743302.

    PMID: 28202457
  8. 8

    Of gains and losses: SAMD9/SAMD9L and monosomy 7 in myelodysplastic syndrome.

    Cammenga J

    Experimental hematology 2024; (134()):104217 doi:10.1016/j.exphem.2024.104217.

    PMID: 38649131
  9. 9

    Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.

    Sahoo SS, Kozyra EJ, Wlodarski MW

    Best practice & research. Clinical haematology 2020; (33(3)):101197 doi:10.1016/j.beha.2020.101197.

    PMID: 33038986
  10. 10

    A diffuse, pustular eruption in a neonate: Recognizing SAMD9L-associated autoinflammatory disease (SAAD).

    Miller MM, Rowe G, O'Brien K, et al.

    Pediatric dermatology 2024; (41(1)):112-114 doi:10.1111/pde.15411.

    PMID: 37571861

This overview of SAAD and the SAMD9L disease spectrum is for education only and does not replace medical advice. A pediatric genetics or specialist team should interpret your child’s results and plan monitoring.